natgillin/translations-raw huggingface dataset:
Pharmacotherapeutic group: Anti-neoplastic agents, protein kinase inhibitor; ATC code: L01XE16.
Farmakoterapeutiline rühm: Kasvajavastased ained – proteiin-kinaasi inhibiitor; ATC-kood: L01XE16.
Pharmacotherapeutic group: Anti-Parkinson-Drugs, Monoamine oxidase -B inhibitors, ATC code: N04BD02
Farmakoterapeutiline grupp: Parkinsoni tõve vastased ravimid, monoamiini oksüdaas -B inhibiitorid, ATC kood: N04BD02
Pharmacotherapeutic group: Antianaemic - ATC code: B03XA.
Farmakoterapeutiline grupp: aneemiavastased ained – ATC kood: B03XA.
Pharmacotherapeutic group: Antianaemic - ATC code: B03XA..
Farmakoterapeutiline grupp: aneemiavastased ained – ATC kood: B03XA.
Pharmacotherapeutic group: antianemic, ATC code: B03XA01 Mechanism of action
Farmakoterapeutiline rühm: aneemiavastased preparaadid, ATC-kood: B03XA01 Toimemehhanism
Pharmacotherapeutic group: Antibacterials for systemic use, carbapenems, ATC code: J01DH04.
Farmakoterapeutiline rühm: antibakteriaalsed ained süsteemseks kasutamiseks, karbapeneemid, ATC- kood: J01DH04.
Pharmacotherapeutic group: Antibacterials for systemic use, glycopeptide antibacterials, ATC code: J01XA03
Farmakoterapeutiline grupp: antibakteriaalsed ained süsteemseks kasutamiseks, glükopeptiidsed antibakteriaalsed ained, ATC-kood: J01XA03
Pharmacotherapeutic group: antibacterials for systemic use, glycopeptide antibacterials, ATC code: J01XA04.
Farmakoterapeutiline rühm: süsteemseks kasutuseks mõeldud antibakteriaalsed ained, antibakteriaalsed glükopeptiidid, ATC-kood: J01XA04.
Pharmacotherapeutic group: Antibacterials for systemic use, Other antibacterials, ATC code: J01XX09
Farmakoterapeutiline rühm: Süsteemsed antibiootikumid, Muud antibiootikumid, ATC-kood: J01XX09
Pharmacotherapeutic group: Antibacterials for systemic use, other cephalosporins, ATC code: J01DI02
Farmakoterapeutiline grupp: Antibakteriaalsed ained süsteemseks kasutamiseks, teised tsefalosporiinid, ATC-kood: J01DI02
Pharmacotherapeutic group: Antibacterials for systemic use, tetracyclines, ATC code: J01AA12.
Farmakoterapeutiline rühm: Antibakteriaalsed ained süsteemseks kasutamiseks, tetratsükliinid, ATC- kood: J01AA12.
Pharmacotherapeutic group: Antibiotics and chemotherapeutics for dermatological use, antivirals, ATC Code: D06BB10
Farmakoterapeutiline rühm: Antibiootikumid ja kemoterapeutikumid dermatoloogiliseks kasutamiseks, viirusevastased ained, ATC-kood: D06BB10.
Pharmacotherapeutic group: Anticholinergics; ATC Code: R03BB05.
Farmakoterapeutiline rühm: antikolinergikud; ATC-kood: R03BB05.
Pharmacotherapeutic group: anticholinesterases, ATC code: N06D A03
Farmakoterapeutiline grupp: koliinesteraasi inhibiitorid, ATC-kood: N06DA03
Pharmacotherapeutic group: Antiemetics and antinauseants, ATC code: A04AD12.
Farmakoterapeutiline rühm: iivelduse- ja oksendamisevastased ained, ATC-kood: A04AD12
Pharmacotherapeutic group: Antiepileptics Other antiepileptics imepitoin ATCvet code: QN03AX90
Farmakoterapeutiline rühm: antiepileptikumid, muud antiepileptikumid, imepitoiin ATCvet kood: QN03AX90
Pharmacotherapeutic group: Antiepileptics, Carboxamide derivatives, ATC code: N03AF04 Mechanism of action
Farmakoterapeutiline grupp: epilepsiaravimid, karboksamiidi derivaadid, ATC-kood: N03AF04 Toimemehhanism
Pharmacotherapeutic group: Antiepileptics, carboxamide derivatives, ATC code: N03AF04 Mechanism of action
Farmakoterapeutiline rühm: epilepsiaravimid, karboksamiidi derivaadid, ATC-kood: N03AF04 Toimemehhanism
Pharmacotherapeutic group: antiepileptics, other antiepileptics, ATC code: N03AX14
Farmakoterapeutiline rühm: epilepsiavastased ained, teised epilepsiavastased preparaadid, ATC-kood: N03AX14.
Pharmacotherapeutic group: Antihaemorrhagic, blood coagulation factor IX; ATC code: B02BD09 Mechanism of action
Farmakoterapeutiline rühm: verejooksu tõkestavad ained, IX hüübimisfaktor; ATC-kood: B02BD09 Toimemehhanism
Pharmacotherapeutic group: Antihaemorrhagics Blood Coagulation factor XIII, ATC code: B02BD11.
Farmakoterapeutiline rühm: antihemorraagilised ained, vere XIII hüübimisfaktor, ATC-kood: B02BD11.
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor IX, ATC code: B02BD04 Mechanism of action
Farmakoterapeutiline rühm: verejooksu tõkestavad ained, IX hüübimisfaktor; ATC-kood: B02BD04 Toimemehhanism
Pharmacotherapeutic Group: antihaemorrhagics, blood coagulation factor IX.
Farmakoterapeutiline grupp: antihemorraagilised ained, verehüübimisfaktor IX.
Pharmacotherapeutic group: antihaemorrhagics, blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapeutiline rühm: verejooksu tõkestavad ained, VIII hüübimisfaktor; ATC-kood: B02BD02 Toimemehhanism
Pharmacotherapeutic group: Antihaemorrhagics: blood coagulation factor VIII, ATC code: B02BD02.
Farmakoterapeutiline rühm: verejooksu tõkestavad ained; vere VIII hüübimisfaktorid, ATC-kood: B02BD02.
Pharmacotherapeutic group: Antihaemorrhagics: Blood coagulation factors, von Willebrand factor and coagulation factor VIII in combination.
Farmakoterapeutiline rühm: verejooksu tõkestavad ained: vere hüübimisfaktorid, von Willebrandi faktori ja VIII faktori kombinatsioon
Pharmacotherapeutic group: antihemorrhagics, blood coagulation factor VIII, ATC code: not yet assigned.
Farmakoterapeutiline grupp: verejooksu tõkestavad ained, vere VIII hüübimisfaktor, ATC kood: B02BD02
Pharmacotherapeutic group: antihemorrhagics, blood coagulation factor VIII, ATC code: not yet assigned.
Farmakoterapeutiline grupp: verejooksu tõkestavad ained, vere VIII hüübimisfaktor, ATC kood: B02BD02.
Pharmacotherapeutic group: antihemorrhagics: blood coagulation factor VIII, ATC code: B02BD02 Mechanism of action
Farmakoterapeutiline rühm: verejooksu tõkestavad ained: VIII hüübimisfaktor ATC-kood: B02BD02 Toimemehhanism
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutiline grupp: antihistamiinsed ained – H1 antagonistid, ATC-kood: R06AX27 Toimemehhanism
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutiline rühm: antihistamiinsed ained – H1 antagonistid, ATC-kood: R06A X27 Toimemehhanism
Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code: R06A X27 Mechanism of action
Farmakoterapeutiline rühm: antihistamiinsed ained – H1 antagonistid, ATC-kood: R06AX27 Toimemehhanism
Pharmacotherapeutic group: Antihypertensives for pulmonary arterial hypertension, ATC code: C02KX05
Farmakoterapeutiline rühm: antihüpertensiivsed ained pulmonaalse arteriaalse hüpertensiooni raviks, ATC-kood: C02KX05.
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Farmakoterapeutiline rühm: mittesteroidsed põletikuvastased ja antireumaatilised ravimid (oksikaamid); ATCvet kood: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet code: QM01AC06
Farmakoterapeutiline rühm: mittesteroidsed valu ja põletikuvastased ained, ATCvet kood: QM01AC06
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATCvet Code: QM01AC06
Farmakoterapeutiline rühm: põletikuvastased ja reumaravimid, mittesteroidsed ravimid (oksikaamid) ATCvet kood: QM01AC06
Pharmacotherapeutic group: Antimetabolites, pyrimidine analogues, ATC code: L01BC01 Mechanism of action
Farmakoterapeutiline grupp: antimetaboliidid, pürimidiini analoogid, ATC kood L01B C01 Toimemehhanism
Pharmacotherapeutic group: Antimycobacterials, drugs for treatment of tuberculosis, ATC code: J04AK05
Farmakoterapeutiline rühm: mükobakterivastased ained, tuberkuloosi raviks kasutatavad ained, ATC- kood: J04AK05
Pharmacotherapeutic group: antimycotics for systemic use, ATC Code: J02AX04 Mechanism of action
Farmakoterapeutiline rühm: seenevastased ained süsteemseks kasutamiseks, ATC-kood: J02AX04 Toimemehhanism
Pharmacotherapeutic group: Antimycotics for systemic use, other antimycotics for systemic use, ATC code: J02AX05
Farmakoterapeutiline rühm: Seentevastased ained süsteemseks kasutamiseks, teised seentevastased ained, mis on mõeldud süsteemseks kasutamiseks, ATC-kood: J0AX05
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02A C03
Farmakoterapeutiline rühm: Süsteemne antimükootiline preparaat, triasooli derivaat, ATC kood: J02AC03
Pharmacotherapeutic group: Antimycotics for systemic use, triazole derivatives, ATC code: J02A C04.
Farmakoterapeutiline rühm: seenevastased ained süsteemseks kasutamiseks, triasooli derivaadid; ATC-kood: J02AC04.
Pharmacotherapeutic group: Antimycotics for systemic use-triazole derivatives, ATC code: J02A C04.
Farmakoterapeutiline grupp: Seenevastased ained süsteemseks kasutamiseks – triasooli derivaadid, ATC-kood: J02A C04.
Pharmacotherapeutic group: antineoplastic agent protein kinase inhibitor, ATC code: L01XE03 Mechanism of action
Farmakoterapeutiline rühm: antineoplastilised ained, proteiinkinaasi inhibiitorid, ATC-kood: L01XE03 Toimemehhanism
Pharmacotherapeutic group: antineoplastic agent, folic acid analogues, ATC code: L01BA04
Farmakoterapeutiline rühm: kasvajavastased ained, foolhappe analoogid, ATC-kood: L01BA04
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, monoclonal antibodies, ATC code: L01XC14
Farmakoterapeutiline rühm: kasvajavastased ained, teised kasvajavastased ained, monoklonaalsed antikehad, ATC-kood: L01XC14
Pharmacotherapeutic group: Antineoplastic agent, other antineoplastic agents, protein kinase inhibitor, ATC code: L01XE07
Farmakoterapeutiline rühm: Antineoplastiline aine, teised antineoplastilised ained, proteiini kinaasi inhibiitor, ATC kood: L01XE07
Pharmacotherapeutic group: Antineoplastic agent, Sensitizers used in photodynamic/radiation therapy, ATC code: L01XD04
Farmakoterapeutiline rühm: kasvajavastane aine, fotodünaamilises ja kiiritusravis kasutatavad sensibileerivad ained, ATC-kood: L01XD04
Pharmacotherapeutic group: Antineoplastic agents - Other alkylating agents, ATC code: L01A X03 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, teised alküülivad ained, ATC-kood: L01A X03 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents - Other alkylating agents, ATC code: L01A X03 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, teised alküülivad ained, ATC-kood: L01AX03 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, Alkylating Agents, ATC code: L01AC01 Mechanism of action
Farmakoterapeutiline grupp: kasvajavastased ained, alküülivad ained, ATC-kood: L01AC01 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, Alkylating Agents, ATC code: L01AC01 Mechanism of action
Farmakoterapeutiline grupp: kasvajavastasedained, alküülivad ained, ATC-kood: L01AC01 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, ATC code: L01BB06.
Farmakoterapeutiline rühm: antineoplastilised ained, antimetaboliidid, ATC-kood: L01BB06.
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, folic acid analogues, ATC code: L01BA04
Farmakoterapeutiline rühm: kasvajavastased ained, antimetaboliidid, foolhappe analoogid, ATC- kood: L01BA04
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, folic acid analogues.
Farmakoterapeutiline rühm: Kasvajavastased ained, antimetaboliidid, foolhappe analoogid.
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, purine analogues, ATC code: L01B B 07
Farmakoterapeutiline rühm: Antineoplastilised ained, antimetaboliidid, puriini analoogid, ATC-kood: L01B B 07
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites, pyrimidine analogues; ATC Code: L01BC08
Farmakoterapeutiline rühm: antineoplastilised ained, antimetaboliidid, pürimidiini analoogid; ATC-kood: L01BC08
Pharmacotherapeutic group: Antineoplastic agents, ATC code: L01XE38 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, ATC-kood: L01XE38 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, folic acid analogues, ATC code: L01BA04
Farmakoterapeutiline rühm: kasvajavastased aained, foolhappe analoogid, ATC-kood: L01BA04
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC06 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, monoklonaalsed antikehad, ATC-kood: L01XC06 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC15 Mechanism of action
Farmakoterapeutiline rühm: Kasvajavastased ained, monoklonaalsed antikehad, ATC-kood: L01XC15 Toimemehhanism
Pharmacotherapeutic group: antineoplastic agents, monoclonal antibodies, ATC code: L01XC16 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, monoklonaalsed antikehad, ATC-kood: L01XC16 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC24 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, monoklonaalsed antikehad, ATC-kood: L01XC24 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies, ATC code: L01XC27 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, monoklonaalsed antikehad, ATC-kood: L01XC27 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, other Antineoplastic agents, ATC code: L01XC19.
Farmakoterapeutiline rühm: Kasvajavastased ained; teised kasvajavastased ained; ATC-kood: L01XC19
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX05.
Farmakoterapeutiline grupp: antineoplastilised ained, ATC kood: L01XX05.
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX05.
Farmakoterapeutiline grupp: antineoplastilised, antineoplastilised ained, ATC kood: L01XX05.
Pharmacotherapeutic group: antineoplastic agents, other antineoplastic agents, ATC code: L01XX47
Farmakoterapeutiline rühm: kasvajavastased ained, teised kasvajavastased ained; ATC-kood: L01XX47
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX48 Mechanism of action
Farmakoterapeutiline rühm: Kasvajavastased ained, teised kasvajavastased ained, ATC-kood: L01XX48 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, protein- kinase inhibitors, ATC code: L01XE11
Farmakoterapeutiline rühm: antineoplastilised ained, teised antineoplastilised ained, proteiinkinaasi inhibiitorid, ATC-kood: L01XE11
Pharmacotherapeutic group: antineoplastic agents, plant alkaloids and other natural products,taxanes, ATC Code: L01CD02
Farmakoterapeutiline rühm: kasvajavastased ained, taimsed alkaloidid ja teised looduslikud ained, taksaanid, ATC kood: L01CD02
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapeutiline rühm: proteiini kinaasi inhibiitorid, ATC-kood: L01XE01 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor, ATC code: L01XE15 Mechanism of action and pharmacodynamic effects
Farmakoterapeutiline rühm: antineoplastilised ained, proteiinkinaasi inhibiitor, ATC-kood: L01XE15 Toimemehhanism ja farmakodünaamilised toimed
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor, ATC code: L01XE23 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, proteiini kinaasi inhibiitor, ATC-kood: L01XE23 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor, ATC code: L01XE25 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, proteiini kinaasi inhibiitor, ATC-kood: L01XE25 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitor; ATC Code: L01XE21
Farmakoterapeutiline rühm: kasvajavastased ained, proteiini kinaasi inhibiitor ATC-kood: L01XE21
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors, ATC code: L01XE13.
Farmakoterapeutiline rühm: antineoplastilised ained, proteiinkinaasi inhibiitorid, ATC-kood: L01XE13.
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE14.
Farmakoterapeutiline rühm: Kasvajavastased ravimid, proteiini kinaasi inhibiitor, ATC-kood: L01XE14.
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors, ATC code: L01XE17
Farmakoterapeutiline rühm: antineoplastilised ravimid, proteiinkinaasi inhibiitorid, ATC-kood: L01XE17
Pharmacotherapeutic group: Antineoplastic agents, protein kinase inhibitors; ATC code: L01X E09
Farmakoterapeutiline rühm: Antineoplastilised ained, proteiini kinaasi inhibiitorid ATC-kood: L01X E09.
Pharmacotherapeutic group: Antineoplastic agents, pyrimidine analogues; ATC code: L01BC07 Mechanism of action
Farmakoterapeutiline rühm: antineoplastilised ained, pürimidiini analoogid; ATC-kood: L01BC07 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic Agents, Taxanes, ATC Code: L01CD 02 Mechanism of action
Farmakoterapeutiline grupp: kasvajavastased ained, taksaanid, ATC-kood: L01CD 02 Toimemehhanism
Pharmacotherapeutic group: antineoplastic agents, taxanes, ATC Code: L01CD02 Mechanism of action
Farmakoterapeutiline grupp: kasvajavastased ained, taksaanid, ATC kood: L01CD 02 Toimemehhanism
Pharmacotherapeutic group: antineoplastic agents, taxanes, ATC Code: L01CD02 Mechanism of action
Farmakoterapeutiline grupp: kasvajavastased ained, taksaanid, ATC kood: L01CD02 Toimemehhanism
Pharmacotherapeutic group: antineoplastic agents, taxanes, ATC Code: L01CD02 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, taksaanid, ATC kood: L01CD02 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic agents, taxanes, ATC code: L01CD04 Mechanism of action
Farmakoterapeutiline rühm: kasvajavastased ained, taksaanid, ATC-kood: L01CD04 Toimemehhanism
Pharmacotherapeutic group: Antineoplastic and immunomodulating agents, ATC code: L01XX51.
Farmakoterapeutiline rühm: Kasvajavastased ja immunomoduleerivad ained, ATC-kood: L01XX51.
Pharmacotherapeutic group: Antineoplastic and immunomodulating agents; immunostimulants; interferons ATC code: L03AB13
Farmakoterapeutiline rühm: kasvajavastased ja immunomoduleerivad ained; immunostimulaatorid; interferoonid, ATC-kood: L03AB13
Pharmacotherapeutic group: antiparasitic product, other anthelmintic agents.
Farmakoterapeutiline rühm: parasiidivastased ained, teised anthelmintikumid.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents – endectocides.
Farmakoterapeutiline rühm: Antiparasiitsed tooted, insektitsiidid ja repellendid – endektotsiidid.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins.
Farmakoterapeutiline grupp: antiparasitaarsed tooted, insektitsiidid ja repellendid, makrotsüklilised laktoonid, milbemütsiinid .
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins.
Farmakoterapeutiline grupp: antiparasitaarsed tooted, insektitsiidid ja repellendid, makrotsüklilised laktoonid, milbemütsiinid.
Pharmacotherapeutic group: Antiparasitic products, insecticides and repellents, other ectoparasiticides for topical use, pyriproxyfen, combinations.
Farmakoterapeutiline rühm: parasiitide vastased ained, insektitsiidid ja repellendid, teised nahaparasiitide vastased ained paikseks kasutamiseks, püriproksüfeen, kombinatsioonid.
Pharmacotherapeutic group: antiparasitic products, insecticides, avermectins, eprinomectin in combinations.
Farmakoterapeutiline rühm: parasiitide vastased ained, insektitsiidid, avermektiinid, eprinomektiin kombineerituna teiste ainetega
Pharmacotherapeutic group: Antiprotozoals, antimalarials, artemisinin and derivatives, combinations, ATC code: P01BF05.
Farmakoterapeutiline rühm: algloomade vastased ained, malaariaravimid, artemisiniin ja derivaadid, kombinatsioonid, ATC-kood: P01BF05
Pharmacotherapeutic group: Antithrombotic agent - direct thrombin inhibitor, ATC Code: B01AE02
Farmakoterapeutiline grupp: tromboosivastane aine - otsene trombiini inhibiitor ATC kood: B01AE02
Pharmacotherapeutic group: Antithrombotic agent – direct thrombin inhibitor, ATC Code: B01AE02
Farmakoterapeutiline grupp: tromboosivastaneaine - otsene trombiini inhibiitor ATC kood: B01AE02
Pharmacotherapeutic group: antithrombotic agent, ATC Code: B01AD07 Mechanism of action
Farmakoterapeutiline grupp: tromboosivastased ravimid, ATC-kood: B01AD07 Toimemehhanism
Pharmacotherapeutic group: Antithrombotic agents, ATC code: B01A D11 Mechanism of action
Farmakoterapeutiline grupp: antitrombootiline preparaat, ATC kood: B01A D11 Toimemehhanism
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC-04.
Farmakoterapeutiline rühm: antitrombootilised ained, trombotsüütide agregatsiooni inhibiitorid, v.a hepariin; ATC-kood: B01AC04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC-04.
Farmakoterapeutiline rühm: tromboosivastased ained,, trombotsüütide agregatsiooni inhibiitorid, v.a hepariin; ATC-kood: B01AC-04.
Pharmacotherapeutic group: antithrombotic, direct thrombin inhibitors, ATC code: B01AE07.
Farmakoterapeutiline grupp: antitrombootilised, otsesed trombiini inhibiitorid, ATC-kood: B01AE07.
Pharmacotherapeutic group: Antiviral for systemic use; antivirals for treatment of HIV infections, combinations.
Farmakoterapeutiline rühm: viirusevastane ravim süsteemseks kasutamiseks; viirusevastased ravimid HIV-infektsioonide raviks, kombinatsioonid.
Pharmacotherapeutic group: Antiviral for systemic use; antivirals for treatment of HIV infections, combinations.
Farmakoterapeutiline rühm: Viirusvastane ravim süsteemseks kasutamiseks; viirusvastased ravimid HIV-infektsioonide raviks, kombinatsioonid.
Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors, ATC code J05AG01.
Farmakoterapeutiline grupp: Viirusevastased ained süsteemseks kasutamiseks,mitte-nukleosiidsed pöördtranskriptaasi inhibiitorid, ATC kood J05AG01.
Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors, ATC code J05AG01.
Farmakoterapeutiline grupp: Viirustevastased ained süsteemseks kasutamiseks, mitte-nukleosiidsed pöördtranskriptaasi inhibiitorid, ATC kood J05AG01.
Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors, ATC code: J05AG04.
Farmakoterapeutiline rühm: viirustevastased ained süsteemseks kasutamiseks, mittenukleosiid- pöördtranskriptaasi inhibiitor, ATC-kood: J05AG04.
Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors.
Farmakoterapeutiline grupp: viirusvastased ained süsteemseks kasutamiseks, mitte-nukleosiidsed pöördtranskriptaasi inhibiitorid.
Pharmacotherapeutic group: antivirals for systemic use, protease inhibitors, ATC code: J05AE09
Farmakoterapeutiline grupp: viirusevastased ained süsteemseks kasutamiseks, proteaasi inhibiitor, ATC-kood: J05A E09
Pharmacotherapeutic group: Antivirals for systemic use, protease inhibitors, ATC code: J05AE10.
Farmakoterapeutiline rühm: viirusevastased ained süsteemseks kasutamiseks, proteaasi inhibiitorid, ATC-kood: J05AE10.
Pharmacotherapeutic group: Antivirals for systemic use; antivirals for treatment of HIV infections, combinations, ATC code: J05AR16
Farmakoterapeutiline rühm: viirusvastased ained süsteemseks kasutamiseks, viirusvastaste ainete kombinatsioonid HIV-infektsiooni raviks, ATC-kood: J05AR16
Pharmacotherapeutic group: Antivirals for systemic use; Direct-acting antiviral, ATC code: J05AX68
Farmakoterapeutiline rühm: viirusvastased ained süsteemseks kasutamiseks; otsese toimega viirusvastased ained, ATC-kood: J05AX68
Pharmacotherapeutic group: Antivirals for treatment of HIV infections, combinations, ATC Code: J05AR01
Farmakoterapeutiline rühm: Viirusevastased ravimid HIV infektsioonide raviks, kombinatsioonid, ATC-kood: J05AR01
Pharmacotherapeutic group: Antivirals for treatment of HIV infections, combinations, ATC Code: J05AR01
Farmakoterapeutiline rühm: Viirusvastaste ainete kombinatsioonid HIV infektsiooni raviks, ATC- kood: J05AR01
Pharmacotherapeutic group: ATC code: D03BA03 bromelains
Farmakoterapeutiline rühm: ATC-kood: D03BA03 bromelains